KALV - KalVista Pharmaceuticals says Venrock Healthcare Capital Partners buys 59.4K shares
2024-01-08 10:10:17 ET
More on KalVista Pharmaceticals
- KalVista: On Demand Oral Treatment For HAE Signifies Differentiated Advancement
- Seeking Alpha’s Quant Rating on KalVista Pharmaceticals
For further details see:
KalVista Pharmaceuticals says Venrock Healthcare Capital Partners buys 59.4K shares